Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Special Opportunities Fund

University of Alberta

$714,250.00

Synthesis, Structural Studies and Evaluation of Inhibitors of the 3CL Protease of SARS-CoV-2 as Potential Drugs for Treating Infection

EF 2019-20

Résumé
No summary - Aucun sommaire
Programme
Special Opportunities Fund
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
549297-2019
Name nom
Lemieux, MaryJoanne
Department département
Biochemistry
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
714250
Program id
SOF
Program name en
Special Opportunities Fund
Program name fr
Fonds d'occasions spéciales
Group en
RESEARCH TRAINING AND TALENT DEVELOPMENT
Group fr
FORMATION EN RECHERCHE ET PERFECTIONNEMENT DES COM
Committee code
996
Committee name en
Scholarships & Fellowships
Committee name fr
Programmes de bourses
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Synthesis, Structural Studies and Evaluation of Inhibitors of the 3CL Protease of SARS-CoV-2 as Potential Drugs for Treating Infection
Keyword
NSERC
Application summary
No summary - Aucun sommaire